Sartorius Stedim Biotech SA (SRTOY)
23.29
-0.99
(-4.08%)
USD |
OTCM |
Oct 08, 16:00
Sartorius Stedim Biotech EPS Diluted (Quarterly) : 0.1111 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1111 |
| March 31, 2026 | 0.1059 |
| December 31, 2025 | 0.0566 |
| September 30, 2025 | 0.0771 |
| June 30, 2025 | 0.0799 |
| March 31, 2025 | 0.0926 |
| December 31, 2024 | 0.05 |
| September 30, 2024 | 0.0288 |
| June 30, 2024 | 0.0527 |
| March 31, 2024 | 0.0629 |
| December 31, 2023 | 0.037 |
| September 30, 2023 | 0.0406 |
| June 30, 2023 | 0.1572 |
| March 31, 2023 | 0.1293 |
| December 31, 2022 | 0.2066 |
| September 30, 2022 | 0.2192 |
| June 30, 2022 | 0.248 |
| March 31, 2022 | 0.3287 |
| December 31, 2021 | 0.0102 |
| September 30, 2021 | 0.1889 |
| June 30, 2021 | 0.1941 |
| March 31, 2021 | 0.1644 |
| December 31, 2020 | 0.1229 |
| September 30, 2020 | 0.1265 |
| June 30, 2020 | 0.0806 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0898 |
| December 31, 2019 | 0.0661 |
| September 30, 2019 | 0.0706 |
| June 30, 2019 | 0.079 |
| March 31, 2019 | 0.0691 |
| December 31, 2018 | 0.0837 |
| September 30, 2018 | 0.0623 |
| June 30, 2018 | 0.0643 |
| March 31, 2018 | 0.0541 |
| December 31, 2017 | 0.0565 |
| September 30, 2017 | 0.0475 |
| June 30, 2017 | 0.0462 |
| March 31, 2017 | 0.0461 |
| December 31, 2016 | 0.0399 |
| September 30, 2016 | 0.0526 |
| June 30, 2016 | 0.0486 |
| March 31, 2016 | 0.0436 |
| December 31, 2015 | 0.0297 |
| September 30, 2015 | 0.0492 |
| June 30, 2015 | 0.0392 |
| March 31, 2015 | 0.0225 |
| December 31, 2014 | 0.025 |
| September 30, 2014 | 0.0279 |
| June 30, 2014 | 0.0279 |
| March 31, 2014 | 0.023 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | -0.1897 |
| Sanofi | -- |
| Codexis, Inc. | -0.1318 |
| Nicox SA | -- |
| Evotec SE | -0.1526 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 108.95M |
| Revenue (Quarterly) | 890.29M |
| Total Expenses (Quarterly) | 782.15M |
| Enterprise Value | 25.18B |
| Gross Profit Margin (Quarterly) | 46.86% |
| Profit Margin (Quarterly) | 12.24% |
| Earnings Yield | 1.51% |
| Operating Earnings Yield | 2.87% |
| Normalized Earnings Yield | 1.758 |